Dendritic and glioma cells fusion vaccine (Second Affiliated Hospital of Zhejiang University School of Medicine)

N/A

Report date: 2025/08/01 20:01:42

Base Information

Drug NameDendritic and glioma cells fusion vaccine (Second Affiliated Hospital of Zhejiang University School of Medicine)
Drug Alias NameDC/tumor cell fusion vaccine
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms, Nerve TissueGlioblastomaGlioma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesSecond Affiliated Hospital Of Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytix IncHangzhou Medical Biotechnology Co LtdSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Active IndicationsN/A
Inactive IndicationsNeoplasms, Nerve TissueGlioblastomaGlioma +[7] 

Other Information

ATC CodeN/A
Related LinksN/A